Smallpox: Anything to declare?

Nature Reviews Immunology

Volumn 2, Issue 7, 2002, Pages 521-527

  Smith, Geoffrey L ^a   McFadden, Grant ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DERIVATIVE; HEXADECYLOXYPROPYLCIDOFOVIR; SMALLPOX VACCINE; UNCLASSIFIED DRUG;

BIOLOGICAL WARFARE; PRIORITY JOURNAL; REVIEW; SMALLPOX; SMALLPOX VIRUS; WORLD HEALTH ORGANIZATION; ART; ARTICLE; HISTORY; HUMAN; VACCINATION;

BIOTERRORISM; HISTORY, 15TH CENTURY; HISTORY, 16TH CENTURY; HISTORY, 17TH CENTURY; HISTORY, 18TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HISTORY, ANCIENT; HISTORY, MEDIEVAL; HUMANS; PORTRAITS; SMALLPOX; SMALLPOX VACCINE; VACCINATION; VARIOLA VIRUS; WORLD HEALTH ORGANIZATION;

EID: 0036635507     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri845     Document Type: Review

References (45)

1. Tucker, J. B. Scourge: The Once and Future Threat of Smallpox (Atlantic Monthly Press, New York, 2001).
2. Henderson, D. A. et al. Smallpox as a biological weapon. J. Am. Med. Assoc. 281, 2127-2137 (1999).
3. Lane, H. C., La Montagne, J. & Fauci, A. S. Bioterrorism: a clear and present danger. Nature Med. 7, 1271-1273 (2001).
4. Razzell, P. Should remaining stocks of smallpox virus be destroyed? Soc. Hist. Med. 8, 305-307 (1995).
5. Ellner, P. D. Smallpox - gone but not forgotten. Infection 26, 263-269 (1998).
6. Birmingham, K. Hopkins Dean criticizes smallpox research. Nature Med. 8, 197-198 (2002).
7. Henderson, D. A. Countering the posteradication threat of smallpox and polio. Clin. Infect. Dis. 34, 79-83 (2002).
8. Leduc, J. W. & Jahrling, P. B. Strengthening national preparedness for smallpox: an update. Emerg. Infect. Dis. 7, 155-157 (2001).
9. Sharma, R. WHO dissenter warns against plans to retain smallpox virus. BMJ 324, 69 (2002).
10. Brundtland, G. H. Smallpox revisted. J. Am. Med. Assoc. 287, 1104 (2002).
11. Enserink, M. & Stone, R. Public health. Dead virus walking. Science 295, 2001-2005 (2002).
12. Alibek, K. Biohazard (Random House, New York, 1999).
13. Miller, J., Engelberg, S. & Broad, W. Germs (Simon & Schuster, New York, 2001).
14. Mahy, B. W. J. et al. The remaining stocks of smallpox virus should be destroyed. Science 262, 1223-1224 (1993).
15. Roizman, B., Joklik, W., Fields, B. & Moss, B. The destruction of smallpox virus stocks in national repositories: a grave mistake and a bad precedent. Infect Agents Dis. 3, 215-217 (1994).
16. Joklik, W. K., Moss, B., Fields, B. N., Bishop, D. H. L. & Sandakhchiev, L. S. Why the smallpox virus stocks should not be destroyed. Science 262, 1225-1226 (1993).
17. Breman, J. G. & Henderson, D. A Diagnosis and management of smallpox. N. Engl. J. Med. 346, 1300-1308.
18. Barquet, N. & Domingo, P. Smallpox: the triumph over the most terrible of the ministers of death. Ann. Intern. Med. 127, 635-642 (1997).
19. Jenner, E. The Origin of the Vaccine Inoculation (Shury, D N., London, 1801).
20. Fenner, F., Anderson, D. A., Arita, I., Jezek, Z. & Ladnyi, I. D. Smallpox and its eradication. World Health Organisation (1988).
21. Shooter, R. A. Report of the investigation into the cause of the 1978 Birmingham smallpox occurrence. London: H. M. Stationery Office (1980).
22. Stone, R. WHO puts off destruction of U. S., Russian caches. Science 295, 598-599 (2002).
23. WHO Advisory Committee on Variola Virus research report of the third meeting, 3-4 December, 2001, Geneva, Switzerland. WHO/CDS/CSR/GAC/2002-3 (2001).
24. Rosenthal, S. R., Merchlinsky, M., Kleppinger, C. & Goldenthal, K. L. Developing new smallpox vaccines Emerg. Infect. Dis. 7, 920-926 (2001).
25. Cohen, J. Smallpox vaccinations: how much protection remains? Science 294, 985 (2001).
26. Henderson, D. A. Smallpox: clinical and epidemiologic features. Emerg. Infect. Dis. 5, 537-539 (1999).
27. Gani, R. & Leach, S. Transmission potential of smallpox in contemporary populations. Nature 414, 748-751 (2001).
28. O'Toole, T. Smallpox: an attack scenario. Emerg. Infect. Dis. 5, 540-546 (1999).
29. Bardi, J. Aftermath of a hypothetical smallpox disaster. Emerg. Infect. Dis. 5, 547-551 (1999).
30. Meltzer, M. I., Damon, I., LeDuc, J. W. & Millar, J. D. Modelling potential responses to smallpox as a bioterrorist weapon. Emerg. Infect. Dis. 7, 959-969 (2001).
31. O'Toole, T., Mair, M. & Inglesby, T. V. Shining light on 'Dark Winter'. Clin. Infect. Dis. 34, 972-983 (2002).
32. Esposito, J. J. & Fenner, F. In Fields Virology 4th edn Vol. 2 (eds Knipe, D. M. & Howley, P. M.) 2885-2921 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
33. Hutin, Y. J. F. et al. Outbreak of human monkeypox. Democratic Republic of Congo, 1996-1997. Emerg. Infect. Dis. 7, 434-438 (2001).
34. Baxby, D. Smallpox-like viruses from camels in Iran. Lancet 2, 1063-1065 (1972).
35. Shchelkunov, S. N. et al. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66-70 (2001).
36. Gubser, C. & Smith, G. L. The sequence of camelpox virus shows it is most closely related to variola virus, the cause of smallpox. J. Gen. Virol. 83, 855-872 (2002).
37. Jackson, R. J. et al. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox. J. Virol. 75, 1205-1210 (2001).
38. Mullbacher, A. & Lobigs, M. Creation of killer poxvirus could have been predicted. J. Virol. 75, 8353-8355 (2001).
39. Lane, J. M., Ruben, F. L., Neff, J. M. & Millar, J. D. Complications of smallpox vaccination, 1968. National surveillance in the United States. N. Engl. J. Med. 281, 1201-1208 (1969).
40. Boulter, E. A. Protection against poxvirses. Proc. Res. Soc. Med. 62, 295-297 (1969).
41. Turner, G. S. & Squires, E. J. Inactivated smallpox vaccine: immunogenicity of inactivated intracellular and extracellular vaccinia virus. J. Gen. Virol. 13, 19-25 (1971).
42. Bradbury, J. Orally available cidofovir derivative active against smallpox. Lancet 359, 1041 (2002).
43. Nomoto, A. & Arita, I. Eradication of poliomyelitis. Nature Immunol. 3, 205-208 (2002).
44. Alfonso, C. L. et al. The genome of camelpox virus. Virology 295, 1-9 (2002).
45. Ramshaw, I. A. et al. Cytokines and immunity to viral infections. Immunol. Rev. 159, 119-135 (1997).